MarginsXMarginsX
Home › Markets › Health Care › CNTB

Connect Biopharma Holdings Limited (CNTB)

CNTB trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.6430
-5.05% on the day
Market cap
$40.5M
Nano cap
Revenue · 2025
$64K
-99.8% on 2024
Net income · 2025
-$55.5M
-86687.5% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1835268/000183526826000013/0001835268-26-000013-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerCNTB on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryChina
IPO year2021
SEC CIK0001835268
SEC industry codePharmaceutical Preparations
Incorporated inCayman Islands

Financials · 2025

LineValue
Revenue$64K
Net income-$55.5M
Operating income-$58.1M
Net margin-86687.5%
Operating margin-90740.6%
Revenue growth-99.8%
Cash$38.3M
Total assets$56.1M
P/E (computed)Net income was not positive
P/S (computed)632.7×

Warning signs

Cash runway
5.4 months
$27.0M cash at June 30, 2026
Share count, 1 year
+13.0%
2025-07-31 to 2026-07-31
Going-concern doubt
No
10-Q filed August 12, 2026
Insider net buying, 12 months
$4.4M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-08-12
Cash and burn$27.0M cash; operating cash flow -$15.1M a quarter.Report 2026-06-30
Shares outstanding62,974,309 (2026-07-31); 55,721,657 a year earlier.Cover page 2026-07-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-05-15
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorCBIZ CPAs P.C., New York, New York, United StatesPCAOB Form AP 2026-04-03
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $4.4M, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$2.8M-$17.3M-$15.9M$27.0MNo debt tags$3.0M10-Q 2026-08-12
Q1 2026
2026-03-31
$169K-$19.4M-$16.0M$46.0MNo debt tags$233K10-Q 2026-05-12
Q4 2025
2025-12-31
$0-$15.1M-$11.3M$38.3MNo debt tags$64K10-K 2026-03-31
Q3 2025
2025-09-30
$16K-$17.2M-$17.4M$37.8MNo debt tags$762K10-Q 2025-11-12
Q2 2025
2025-06-30
$48K-$12.9M-$12.6M$40.6MNo debt tags$2.0M10-Q 2026-08-12
Q1 2025
2025-03-31
$0-$10.3M-$10.0M$47.7MNo debt tags$26.0M10-Q 2026-05-12
Q4 2024
2024-12-31
$698K-$8.9M-$2.3M$78.2MNo debt tags$26.0M10-K 2026-03-31
Q3 2024
2024-09-30
$1.2M-$12.9M-$13.0M$97.2MNo debt tagsNeeds four quarters10-Q 2025-11-12

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentF-32026-05-15
Latest annual report10-K2026-03-31
Latest quarterly / interim10-Q2026-11-16
Latest current report8-K2026-11-16

Source: SEC EDGAR submissions feed, 198 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-7.1%
1 month-26.3%
3 months-73.3%
Year to date-76.0%
1 year-59.7%
From 52-week high-81.7%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
DWTXDogwood Therapeutics Inc.$1.06-8.62%$40.5M
ALDXAldeyra Therapeutics Inc.$0.6696+4.01%$40.4M
GANXGain Therapeutics Inc.$0.9402-9.60%$41.9M
ELTXElicio Therapeutics Inc.$1.48-1.33%$41.9M
IBOImpact BioMedical Inc.$4.91-4.47%$42.4M
HYPDHyperion DeFi Inc.$2.47-4.26%$38.3M
PLRXPliant Therapeutics Inc.$0.6932-0.55%$43.0M
BMEABiomea Fusion Inc.$0.5201-10.67%$37.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier